What is the growth forecast for the In Vitro Assays market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the In Vitro Assays market?

Key drivers include rising infectious disease prevalence and advancements in diagnostic technologies.

What challenges does the In Vitro Assays market face?

Challenges include high development costs and stringent regulatory requirements.

Which regions are leading the In Vitro Assays market?

North America and Europe are leading the market due to strong healthcare infrastructure.

Who are the top companies in the In Vitro Assays market?

Top companies include Roche, Abbott, and bioMerieux, offering a range of diagnostic solutions.

What future opportunities exist in the In Vitro Assays market?

Future opportunities include emerging markets and the development of point-of-care diagnostics.

How is technology impacting the In Vitro Assays market?

Technology advancements are improving diagnostic accuracy and speed, driving market growth.

What is the current regulatory landscape for In Vitro Assays?

The regulatory landscape is evolving, with increasing focus on safety and efficacy.

What is the future outlook for the In Vitro Assays to Diagnose Infectious Diseases market?

The future outlook is positive, with growing demand for effective diagnostic solutions.

In Vitro Assays to Diagnose Infectious Diseases Market Comprehensive Report: 200+ Pages | 2026–2034

In Vitro Assays to Diagnose Infectious Diseases by Application (/> Streptococcus, Clostridium Difficile, Candida, Tuberculosis, Others), by Type (/> Immunoassay, Molecular Diagnosis, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

In Vitro Assays to Diagnose Infectious Diseases Market Overview

The In Vitro Assays to Diagnose Infectious Diseases market refers to the industry that develops and manufactures in vitro diagnostic tests to detect and diagnose infectious diseases. As the In Vitro Assays to Diagnose Infectious Diseases market size is expected to reach $4.8 billion by 2026, the growth outlook and market forecast indicate a promising industry expansion driven by the increasing prevalence of infectious diseases, advancements in technology, and growing demand for rapid and accurate diagnostic tests. The scope of this market includes various types of in vitro assays such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and lateral flow assays, which are used to diagnose infectious diseases such as COVID-19, tuberculosis, and HIV.

Loading chart…

The In Vitro Assays to Diagnose Infectious Diseases market is expected to grow at a CAGR of 7.5% from 2026 to 2033, driven by macro drivers such as the increasing burden of infectious diseases, advancements in technology, and growing demand for rapid and accurate diagnostic tests. Key forces shaping the industry include technology shifts towards molecular diagnostics, regulations such as the increasing stringency of diagnostic test approvals, and competitive intensity driven by the entry of new players. The largest region in the In Vitro Assays to Diagnose Infectious Diseases market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing prevalence of infectious diseases and growing demand for diagnostic tests in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	26.10 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	QIAGEN; BD; bioMerieux SA; F. Hoffmann-La Roche, Ltd.; Hologic, Inc. (Gen-Probe); Abbott; Quidel Corp.、; iemens Healthineers AG; Bio-Rad Laboratories, Inc.; Danaher Corp.; OraSure Technologies, Inc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The In Vitro Assays to Diagnose Infectious Diseases market is witnessing significant growth, driven by increasing demand for rapid and accurate diagnostic tests. The market dynamics are influenced by various factors, including technological advancements, regulatory requirements, and shifting consumer preferences.

Growth Drivers2 items

Advances in molecular diagnostics and genomics are enabling the development of highly sensitive and specific in vitro assays, driving growth in the In Vitro Assays to Diagnose Infectious Diseases market.

Government initiatives and funding for research and development in infectious disease diagnosis are contributing to the expansion of the In Vitro Assays to Diagnose Infectious Diseases market size.

Restraints2 items

High development costs and regulatory hurdles are limiting the entry of new players in the In Vitro Assays to Diagnose Infectious Diseases market, restraining market growth.

The lack of standardization in in vitro assay development and validation is creating challenges for manufacturers and end-users, affecting the overall growth forecast of the market.

Opportunities2 items

The increasing prevalence of infectious diseases in emerging economies presents opportunities for manufacturers to expand their product offerings and reach new customers in these regions, driving growth in the In Vitro Assays to Diagnose Infectious Diseases market.

The growing demand for point-of-care diagnostics is creating opportunities for developers of rapid and portable in vitro assays, which can provide accurate and reliable results in remote or resource-limited settings.

Challenges2 items

The complexity of infectious disease diagnosis and the need for highly sensitive and specific assays pose significant challenges for manufacturers, requiring significant investment in research and development.

The competitive landscape of the In Vitro Assays to Diagnose Infectious Diseases market is intense, with several established players competing for market share, making it challenging for new entrants to gain traction and achieve sustainable growth.

Market Segmentation

Loading chart…

The Application segment of the In Vitro Assays to Diagnose Infectious Diseases market is a critical component, accounting for a significant portion of the overall market size. This segment is further divided into subtypes, including diagnostic and research applications. The diagnostic applications are primarily used for the detection and diagnosis of infectious diseases, while the research applications are used to understand the underlying mechanisms of these diseases. Understanding the In Vitro Assays to Diagnose Infectious Diseases segmentation is crucial for industry players to develop targeted strategies and products.

The Type segment of the In Vitro Assays to Diagnose Infectious Diseases market is another key area of focus, comprising various subtypes such as ELISA, PCR, and immunofluorescence assays. Each of these subtypes has its own strengths and weaknesses, and contributes to the overall market size. For instance, ELISA assays are widely used for the detection of infectious diseases due to their high sensitivity and specificity, while PCR assays are used for the detection of specific genetic material. Analyzing the market taxonomy of the In Vitro Assays to Diagnose Infectious Diseases market is essential to understand the dynamics of this segment.

In Vitro Assays to Diagnose Infectious Diseases Segmentation Breakdown10 items

Application

/> Streptococcus

Clostridium Difficile

Candida

Tuberculosis

Others

Type

/> Immunoassay

Molecular Diagnosis

Others

Regional Insights

Loading chart…

The In Vitro Assays to Diagnose Infectious Diseases market growth is anticipated to be driven by various regional factors. North America is expected to be the largest region, driven by key drivers such as high adoption of advanced diagnostic technologies, favorable policies supporting research and development, and significant investments in healthcare infrastructure. Europe is also expected to contribute significantly to the market growth, driven by established healthcare systems, growing demand for diagnostic services, and increasing awareness about infectious diseases.

The fastest-growing region is expected to be Asia Pacific, driven by rapidly expanding healthcare infrastructure, increasing investments in research and development, and growing demand for diagnostic services. Latin America and Middle East & Africa are also expected to contribute to the market growth, driven by improving healthcare systems, growing awareness about infectious diseases, and increasing adoption of advanced diagnostic technologies. The regional forecast indicates a significant growth opportunity for the In Vitro Assays to Diagnose Infectious Diseases market in the coming years.

Key Drivers by Region5 items

North America: high adoption, favorable policies, significant investments

Europe: established healthcare systems, growing demand, increasing awareness

Asia Pacific: rapidly expanding infrastructure, increasing investments, growing demand

Latin America: improving healthcare systems, growing awareness, increasing adoption

Middle East & Africa: improving healthcare systems, growing awareness, increasing adoption

Competitive Landscape

The In Vitro Assays to Diagnose Infectious Diseases market exhibits a moderately consolidated structure, driven by both global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The In Vitro Assays to Diagnose Infectious Diseases competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios and service models.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. However, they face challenges such as margin pressure, compliance costs, and commoditization. To differentiate themselves, companies focus on technology, service models, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies:

QIAGEN: regional expansion

BD: vertical integration

bioMerieux SA: premium pricing

F. Hoffmann-La Roche, Ltd.: innovation pipeline

Hologic, Inc.: OEM tie-ups

Abbott: local manufacturing

Key In Vitro Assays to Diagnose Infectious Diseases Companies11 items

QIAGEN

bioMerieux SA

F. Hoffmann-La Roche, Ltd.

Hologic, Inc. (Gen-Probe)

Abbott

Quidel Corp.、

iemens Healthineers AG

Bio-Rad Laboratories, Inc.

Danaher Corp.

OraSure Technologies, Inc

Market Ecosystem

The In Vitro Assays to Diagnose Infectious Diseases ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of in vitro assays, as well as the provision of related services. The ecosystem is characterized by a complex interplay between various participants, each playing a distinct role in the value chain analysis.

Raw material/component suppliers — providing critical reagents and materials

Technology providers — developing and licensing assay technologies

OEMs / manufacturers — producing in vitro assay kits and instruments

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering technical support and maintenance services

End users / buyers — utilizing in vitro assays for diagnostic purposes

Regulators/standards bodies — establishing guidelines and standards for assay development and use

The flow of value through the In Vitro Assays to Diagnose Infectious Diseases ecosystem is influenced by various control points, including regulatory approvals, technology licensing, and distribution agreements. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact assay development and adoption. Switching costs and interoperability requirements can also affect the ecosystem, particularly for end users who may be invested in specific technologies or platforms. Furthermore, regional differences in regulatory frameworks, healthcare systems, and market demands can lead to variations in the ecosystem across different regions.

Recent Industry Insights

The In Vitro Assays to Diagnose Infectious Diseases industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between major pharmaceutical companies and specialized diagnostic firms, have accelerated innovation in the field. Mergers and acquisitions, including the acquisition of small biotech companies by industry leaders, have also played a crucial role in shaping the industry landscape.

Additionally, several product launches have taken place, introducing advanced technologies and diagnostic solutions to the market. Regulatory changes, such as the updated guidelines for in vitro diagnostic devices, have also impacted the industry. Furthermore, a shift in consumer trends towards preventive healthcare and increased funding for research and development have driven growth in the In Vitro Assays to Diagnose Infectious Diseases market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the In Vitro Assays to Diagnose Infectious Diseases market outlook. The market attractiveness is high due to the increasing prevalence of infectious diseases and the need for accurate diagnosis. The competitive intensity is moderate, with key players investing in research and development to improve assay sensitivity and specificity. The long-term outlook is positive, driven by advancements in technology and the growing demand for point-of-care diagnostics.

The innovation landscape is evolving rapidly, with a focus on molecular diagnostics and next-generation sequencing. The demand-supply balance is expected to be stable, with manufacturers increasing production to meet the rising demand. However, key risk factors include regulatory changes and supply chain disruptions. Overall, the market is poised for growth, and stakeholders must stay informed about the latest trends and developments to remain competitive.

11 items

1. Executive Summary

2. In Vitro Assays to Diagnose Infectious Diseases Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global In Vitro Assays to Diagnose Infectious Diseases Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global In Vitro Assays to Diagnose Infectious Diseases Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. /> Streptococcus

6.1.2. Clostridium Difficile

6.1.3. Candida

6.1.4. Tuberculosis

6.1.5. Others

6.2. Global In Vitro Assays to Diagnose Infectious Diseases Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.2.1. /> Immunoassay

6.2.2. Molecular Diagnosis

6.2.3. Others

6.3. Global In Vitro Assays to Diagnose Infectious Diseases Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global In Vitro Assays to Diagnose Infectious Diseases Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global In Vitro Assays to Diagnose Infectious Diseases Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global In Vitro Assays to Diagnose Infectious Diseases Market Competition by Key Manufacturers

8.1. Global In Vitro Assays to Diagnose Infectious Diseases Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global In Vitro Assays to Diagnose Infectious Diseases: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. QIAGEN

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. bioMerieux SA

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. F. Hoffmann-La Roche, Ltd.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Hologic, Inc. (Gen-Probe)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abbott

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Quidel Corp.、

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. iemens Healthineers AG

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Bio-Rad Laboratories, Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Danaher Corp.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. OraSure Technologies, Inc

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global In Vitro Assays to Diagnose Infectious Diseases Market

Figure 4: Global In Vitro Assays to Diagnose Infectious Diseases Market: Drivers

Figure 5: Global In Vitro Assays to Diagnose Infectious Diseases Market: Challenges

Figure 6: Global In Vitro Assays to Diagnose Infectious Diseases Market: Trends

Figure 7: Global In Vitro Assays to Diagnose Infectious Diseases Market: Opportunity

Figure 8: Global In Vitro Assays to Diagnose Infectious Diseases Market: Restraint

Figure 9: Global In Vitro Assays to Diagnose Infectious Diseases Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global In Vitro Assays to Diagnose Infectious Diseases Market Value (USD Million) By Region

Figure 15: Global In Vitro Assays to Diagnose Infectious Diseases Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Type

Figure 21: Global Market Share (%) By Type (2032)

Figure 22: Global In Vitro Assays to Diagnose Infectious Diseases Market Value (USD Million) By Region

Figure 23: Global In Vitro Assays to Diagnose Infectious Diseases Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global In Vitro Assays to Diagnose Infectious Diseases Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global In Vitro Assays to Diagnose Infectious Diseases Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global In Vitro Assays to Diagnose Infectious Diseases Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global In Vitro Assays to Diagnose Infectious Diseases Market Value (USD Million) By Region

Table 10: Global In Vitro Assays to Diagnose Infectious Diseases Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Type

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Type

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Type

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 26: Global In Vitro Assays to Diagnose Infectious Diseases Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global In Vitro Assays to Diagnose Infectious Diseases Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global In Vitro Assays to Diagnose Infectious Diseases Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: QIAGEN Basic Information And Sales Area

Table 31: QIAGEN. Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: bioMerieux SA Basic Information And Sales Area

Table 35: bioMerieux SA. Products Portfolio

Table 36: F. Hoffmann-La Roche, Ltd. Basic Information And Sales Area

Table 37: F. Hoffmann-La Roche, Ltd.. Products Portfolio

Table 38: Hologic, Inc. (Gen-Probe) Basic Information And Sales Area

Table 39: Hologic, Inc. (Gen-Probe). Products Portfolio

Table 40: Abbott Basic Information And Sales Area

Table 41: Abbott. Products Portfolio

Table 42: Quidel Corp.、 Basic Information And Sales Area

Table 43: Quidel Corp.、. Products Portfolio

Table 44: iemens Healthineers AG Basic Information And Sales Area

Table 45: iemens Healthineers AG. Products Portfolio

Table 46: Bio-Rad Laboratories, Inc. Basic Information And Sales Area

Table 47: Bio-Rad Laboratories, Inc.. Products Portfolio

Table 48: Danaher Corp. Basic Information And Sales Area

Table 49: Danaher Corp.. Products Portfolio

Table 50: OraSure Technologies, Inc Basic Information And Sales Area

Table 51: OraSure Technologies, Inc. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Type

Table 55: Global Market Share (%) By Type (2032)

Table 56: Global In Vitro Assays to Diagnose Infectious Diseases Market Value (USD Million) By Region

Table 57: Global In Vitro Assays to Diagnose Infectious Diseases Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Type

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Type

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Type

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

In Vitro Assays to Diagnose Infectious Diseases Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	26.10 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	QIAGEN; BD; bioMerieux SA; F. Hoffmann-La Roche, Ltd.; Hologic, Inc. (Gen-Probe); Abbott; Quidel Corp.、; iemens Healthineers AG; Bio-Rad Laboratories, Inc.; Danaher Corp.; OraSure Technologies, Inc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High development costs and regulatory hurdles are limiting the entry of new players in the In Vitro Assays to Diagnose Infectious Diseases market, restraining market growth.

The lack of standardization in in vitro assay development and validation is creating challenges for manufacturers and end-users, affecting the overall growth forecast of the market.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

In Vitro Assays to Diagnose Infectious Diseases Segmentation Breakdown10 items

Application

/> Streptococcus

Clostridium Difficile

Candida

Tuberculosis

Others

Type

/> Immunoassay

Molecular Diagnosis

Others

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: high adoption, favorable policies, significant investments

Europe: established healthcare systems, growing demand, increasing awareness

Asia Pacific: rapidly expanding infrastructure, increasing investments, growing demand

Latin America: improving healthcare systems, growing awareness, increasing adoption

Middle East & Africa: improving healthcare systems, growing awareness, increasing adoption

Competitive Landscape

QIAGEN: regional expansion

BD: vertical integration

bioMerieux SA: premium pricing

F. Hoffmann-La Roche, Ltd.: innovation pipeline

Hologic, Inc.: OEM tie-ups

Abbott: local manufacturing

Key In Vitro Assays to Diagnose Infectious Diseases Companies11 items

QIAGEN

bioMerieux SA

F. Hoffmann-La Roche, Ltd.

Hologic, Inc. (Gen-Probe)

Abbott

Quidel Corp.、

iemens Healthineers AG

Bio-Rad Laboratories, Inc.

Danaher Corp.

OraSure Technologies, Inc

Market Ecosystem

Raw material/component suppliers — providing critical reagents and materials

Technology providers — developing and licensing assay technologies

OEMs / manufacturers — producing in vitro assay kits and instruments

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering technical support and maintenance services

End users / buyers — utilizing in vitro assays for diagnostic purposes

Regulators/standards bodies — establishing guidelines and standards for assay development and use

Recent Industry Insights

Analyst Overview

Table of Contents